BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 22067179)

  • 1. Intramural and mesorectal distal spread detected by whole-mount sections in the determination of optimal distal resection margin in patients undergoing surgery for rectosigmoid or rectal cancer without preoperative therapy.
    Shimada Y; Takii Y; Maruyama S; Ohta T
    Dis Colon Rectum; 2011 Dec; 54(12):1510-20. PubMed ID: 22067179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    Law WL; Chu KW
    J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional micrometastasis of low rectal cancer in mesorectum: a study utilizing HE stain on whole-mount section and ISH analyses on tissue microarray.
    Wang Z; Zhou ZG; Wang C; Zheng XL; Wang R; Li FY; Guo J; Jiang LL
    Cancer Invest; 2006; 24(4):374-81. PubMed ID: 16777689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with oncologic outcomes after abdominoperineal resection compared with restorative resection for low rectal cancer: patient- and tumor-related or technical factors only?
    Reshef A; Lavery I; Kiran RP
    Dis Colon Rectum; 2012 Jan; 55(1):51-8. PubMed ID: 22156867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution of micrometastatic nodules of low rectal cancer in mesorectum: a pathological study using whole-mount sections].
    Wang Z; Zhou ZG; Wang C; Han FH; Chen YD; Yan WW; Gao HK; Wang Y; Li HG
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):361-3. PubMed ID: 17045001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
    den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
    Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of the continence function after intersphincteric resection using a prolapsing technique in the patients with low rectal cancer and its clinical prognosis.
    Dai Y; Jiang JB; Bi DS; Jin ZT; Sun JZ; Hu SY
    Chin Med J (Engl); 2008 Oct; 121(20):2016-20. PubMed ID: 19080267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
    Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S
    Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.
    Wibe A; Syse A; Andersen E; Tretli S; Myrvold HE; Søreide O;
    Dis Colon Rectum; 2004 Jan; 47(1):48-58. PubMed ID: 14719151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spread of rectal cancer in the distal mesorectum: a report of 46 cases].
    Zhang WJ; Chen JP
    Ai Zheng; 2008 Jul; 27(7):752-5. PubMed ID: 18606071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
    Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
    Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: treatment with radiotherapy and chemotherapy.
    Burton S; Brown G; Daniels I; Norman A; Swift I; Abulafi M; Wotherspoon A; Tait D
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):445-51. PubMed ID: 16690432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic versus open surgery for rectosigmoid and rectal cancer.
    Sahakitrungruang C; Pattana-arun J; Tantiphlachiva K; Rojanasakul A
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S59-64. PubMed ID: 16623004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns of lymphatic spread of sigmoid, rectosigmoid, and rectal cancers.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2008 Dec; 15(12):3478-83. PubMed ID: 18830668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance of a 5-mm distal bowel resection margin for rectal cancer: is it safe?
    Rutkowski A; Nowacki MP; Chwalinski M; Oledzki J; Bednarczyk M; Liszka-Dalecki P; Gornicki A; Bujko K
    Colorectal Dis; 2012 Jan; 14(1):71-8. PubMed ID: 21199273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
    Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
    Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.